Improving Clinical Trial Awareness in NSCLC: Pilot Testing A Novel Healthcare IT Platform for Incorporating Education at the Point of Care

Abramson Cancer Center at Penn Medicine

Status

Completed

Conditions

Non-Small Cell Lung Carcinoma (NSCLC)

Treatments

Other: Survey

Study type

Interventional

Funder types

Other

Identifiers

NCT02558998

UPCC 34514

Details and patient eligibility

About

The objective of this study is to 1) evaluate the impact of a novel individualized care planning/ educational technology (the On Q Care Planning System or CPS) on oncology patient and provider knowledge, attitudes and beliefs about Non-Small Cell Lung Carcinoma (NSCLC) clinical trials, as well as 2) to evaluate the impact of the On Q CPS on patient referral to and enrollment in NSCLC clinical trials.

Enrollment

120 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

All participants must be 18 years of age or older.
Patient participants must have Stage III, IV and/or recurrent NSCLC.
Patient participants must be at a point of treatment initiation/change or evaluation for treatment initiation/change
Patients must have working email address and internet access

Exclusion criteria

Any participant who cannot understand written or spoken English.
Any participant who is not competent to provide informed consent for study participation per the investigator.
Any participant who cannot be present for the related study visits and/or complete the post-test assessment